TY - JOUR
T1 - Evaluation of Completeness of Information in Patient Information Leaflets of Registered Medications
T2 - A Comprehensive Review
AU - Ishaqui, Azfar Athar
AU - Murad, Shomaiza Andleeb
AU - Bufail, Dua
AU - Sahar, Tuba
AU - Faraz, Saira
AU - Lodhi, Muneeza
AU - Alam, Shoaib
AU - Aziz, Samreen
AU - Maqsood, Muhammad Bilal
AU - Ahmed, Zeeshan
AU - Imran, Muhammad
AU - Jawed, Lailoona
AU - Farooq, Javeria
AU - Iqbal, Adnan
AU - Ahmad, Salman Ashfaq
N1 - Publisher Copyright:
© 2023, Colegio de Farmaceuticos de la Provincia de Buenos Aires. All rights reserved.
PY - 2023
Y1 - 2023
N2 - Patient information leaflets includes information about the appropriate usage of medication. The information provided in the leaflet should be easy to understand. Moreover, the information needs to be comprehensive to guide the healthcare professionals to ensure the optimal use of medication. The current study aimed to assess the completeness of information mentioned in the medication leaflets. The medication leaflets of tablet dosage forms of local pharmaceutical companies were collected and assessed for various pa-rameters such dosing of medication, drug interaction, medication safety, storage instructions, adverse effects etc. a total of 187 leaflets were assessed for completeness of information. Information about renal and hepatic dose adjustment was present in only 32% leaflets. The maximum dose per day was missing in about half of the studied leaflets. The instructions about use in lactation period was mentioned in around 71% leaflets. Drug food interactions were mentioned in only 3.2% leaflets. Drug-drug interactions were missing in around one-third leaflets. The instructions about food needs to be avoided with medication administration was stated in only 6.5% leaflets. Pharmacokinetics parameter was observed in around 56.6% leaflets. The study concludes that most of the leaflets lack some of the important medication information.
AB - Patient information leaflets includes information about the appropriate usage of medication. The information provided in the leaflet should be easy to understand. Moreover, the information needs to be comprehensive to guide the healthcare professionals to ensure the optimal use of medication. The current study aimed to assess the completeness of information mentioned in the medication leaflets. The medication leaflets of tablet dosage forms of local pharmaceutical companies were collected and assessed for various pa-rameters such dosing of medication, drug interaction, medication safety, storage instructions, adverse effects etc. a total of 187 leaflets were assessed for completeness of information. Information about renal and hepatic dose adjustment was present in only 32% leaflets. The maximum dose per day was missing in about half of the studied leaflets. The instructions about use in lactation period was mentioned in around 71% leaflets. Drug food interactions were mentioned in only 3.2% leaflets. Drug-drug interactions were missing in around one-third leaflets. The instructions about food needs to be avoided with medication administration was stated in only 6.5% leaflets. Pharmacokinetics parameter was observed in around 56.6% leaflets. The study concludes that most of the leaflets lack some of the important medication information.
KW - drug
KW - drug information
KW - lactation
KW - leaflets
KW - pregnancy
KW - tablets
UR - http://www.scopus.com/inward/record.url?scp=85176388784&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:85176388784
SN - 0326-2383
VL - 42
SP - 2343
EP - 2349
JO - Latin American Journal of Pharmacy
JF - Latin American Journal of Pharmacy
IS - 11
ER -